Prestige Consumer Healthcare PBH International OTC Healthcare — Total revenues
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Prestige Consumer Healthcare in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prestige Consumer Healthcare's international otc healthcare — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Prestige Consumer Healthcare's international OTC healthcare — total revenues?
- Prestige Consumer Healthcare (PBH) reported international OTC healthcare — total revenues of $47.07M in Q1 2026.
- How has Prestige Consumer Healthcare's international OTC healthcare — total revenues changed year-over-year?
- Prestige Consumer Healthcare's international OTC healthcare — total revenues decreased by 1.0% year-over-year, from $47.57M to $47.07M.
- What is the long-term trend for Prestige Consumer Healthcare's international OTC healthcare — total revenues?
- Over 4 years (2022 to 2026), Prestige Consumer Healthcare's international OTC healthcare — total revenues has grown at a 10.2% compound annual growth rate (CAGR), from $118.93M to $175.13M.
- What does international OTC healthcare — total revenues mean?
- The total gross sales generated by the international OTC healthcare segment before the deduction of cost of sales and operating expenses. This metric measures the top-line performance and market demand for the company's products in international markets. It is the primary indicator of the segment's scale and growth trajectory.